Ethos Technologies’ Earnings Call Highlights Profitable Growth

Ethos Technologies Inc. Class A ((LIFE)) has held its Q4 earnings call. Read on for the main highlights of the call.

Ethos Technologies’ latest earnings call struck an upbeat tone, with management leaning into rapid growth, expanding profitability and clear technology advantages. Executives acknowledged working-capital and product-launch risks but framed them as manageable against a backdrop of surging revenues, strong unit economics and rising agent and customer engagement.

Explosive Quarterly Revenue Growth

Ethos reported Q4 revenue of $110.1 million, up 65% year over year, underscoring continued momentum despite a choppy macro backdrop. Growth was broad-based across both direct and third‑party channels, signaling that demand is scaling beyond the company’s core consumer-facing funnel.

Scaling Profitability With Strong EBITDA Margins

Adjusted EBITDA for Q4 came in around $25.8 million to $26 million, translating to a 23% margin and highlighting growing earnings power. Management emphasized that profitability is rising alongside growth, not after it, suggesting the model scales efficiently as volumes increase.

Direct Channel Delivers Outsized Gains

The direct-to-consumer channel was a standout, with Q4 D2C revenue of $74.2 million, up 93% year over year. Executives attributed this surge to improved marketing efficiency, better conversion rates and enhanced underwriting, all of which lowered acquisition costs while boosting volumes.

Policy Momentum and Expanding Agent Network

Ethos activated 54,714 new policies in Q4, a 42% annual increase, and surpassed 500,000 policies cumulatively by year-end. The platform now has more than 15,000 agents selling in 2025, expanding distribution reach and underscoring growing adoption among traditional intermediaries.

Full-Year Growth and Lean Operating Metrics

For 2025, revenue reached $388 million, up 52% and marking a third straight year of growth above 50%. Contribution profit in Q4 was $47.2 million with a 43% contribution margin and a roughly two‑month payback on variable costs, pointing to disciplined spending and efficient unit economics.

Balance Sheet Strength and Receivable Overhang

The company ended 2025 with $157.4 million in cash, cash equivalents and investments, providing ample liquidity to fund growth. A $290 million commission receivable balance is expected to convert over several years, but it introduces working-capital timing risk and some collection uncertainty.

AI-Driven Underwriting and Testing Velocity

Ethos highlighted a 95% instant decisioning rate and a claimed 98% gross margin, driven by AI, machine learning and a tightly integrated data stack. Testing cycles have accelerated dramatically, from about three weeks in 2023 to as little as three days by January 2026, enabling faster iterations across products and pricing.

New Products Show Promise, With Caveats

Two products launched in Q4 illustrate Ethos’ expansion push: an accumulation indexed universal life offering with North American Sammons and a supplementary cancer product with Aflac. While the IUL line is seeing healthy agent uptake, the cancer product remains in very early tests, making its ultimate scale and economics uncertain.

Guidance Signals Continued Growth, Slower Pace

For Q1 2026, Ethos guided revenue to $144–$146 million, implying about 53% growth, and adjusted EBITDA to $30–$32 million, reinforcing confidence in near-term momentum. Full‑year 2026 guidance of $510–$514 million in revenue, or roughly 32% growth, and $99–$103 million in adjusted EBITDA points to ongoing expansion, albeit at a moderated pace.

Rule of 40, Customer Loyalty and Market Risks

Management highlighted a Rule of 40 score of 75 and a Net Promoter Score above 70, signaling a rare combination of rapid growth, profitability and customer satisfaction. Still, the team acknowledged investor jitters around AI, regulatory constraints on algorithmic underwriting and broader macro and seasonal variability as areas to watch.

Product Launch Friction and Carrier Concentration

Ethos noted that new product launches can take four months to a year and require full‑company integration, adding cost and potentially slowing the rollout cadence. The business also leans on a focused panel of six carriers, an intentional but concentrated setup that management expects to gradually diversify over time.

Seasonality and Mid-Year Moderation Dynamics

The company reminded investors that Q1 and Q4 are historically the strongest quarters, with Q2 and Q3 seeing softer seasonal tailwinds. This pattern, combined with evolving product ramps, is likely to produce lumpier mid‑year results and may require more nuanced modeling from analysts.

Ethos’ earnings call painted the picture of a tech-forward insurer delivering rapid growth, rising profitability and strong customer advocacy while transparently flagging capital, product and regulatory risks. For investors, the story is shifting from pure top-line acceleration to proving that these economics remain durable as growth moderates and the product set expands.